GOVX · GeoVax Labs Inc. Common Stock
View on chartInsiders & Stakes
| DODD DAVID A President, CEO | ▲ Buy | Open Market | 36,661 Shares held | 4/1/2025 | View profile |
| CHASE RANDAL D Director | ▲ Buy | Open Market | 36,613 Shares held | 9/21/2022 | View profile |
| SPENCER JOHN N JR Director | ▲ Buy | Open Market | 21,402 Shares held | 10/17/2025 | View profile |
| Reynolds Mark CFO | ▲ Buy | Open Market | 14,013 Shares held | 3/31/2025 | View profile |
| Sharkey John W. VP, Business Development | ▲ Buy | Open Market | 6,191 Shares held | 4/10/2025 | View profile |
| McKee Kelly T. Jr. Chief Medical Officer | ▲ Buy | Open Market | 3,494 Shares held | 8/7/2025 | View profile |
Transaction History
| SPENCER JOHN N JR | ▲ Buy | Open Market | 10,000 | $5K | 10/17/2025 |
| McKee Kelly T. Jr. | ▲ Buy | Open Market | 1,107 | $742 | 8/7/2025 |
| SPENCER JOHN N JR | ▲ Buy | Open Market | 10,000 | $10K | 4/10/2025 |
| Sharkey John W. | ▲ Buy | Open Market | 6,000 | $6K | 4/10/2025 |
| DODD DAVID A | ▲ Buy | Open Market | 10,000 | $11K | 4/1/2025 |
| Reynolds Mark | ▲ Buy | Open Market | 6,800 | $7K | 3/31/2025 |
| DODD DAVID A | ▲ Buy | Open Market | 8,000 | $16K | 8/9/2024 |
| DODD DAVID A | ▲ Buy | Open Market | 8,209 | $19K | 2/22/2024 |
| DODD DAVID A | ▲ Buy | Open Market | 520 | $1K | 2/21/2024 |
| Reynolds Mark | ▲ Buy | Open Market | 2,000 | $6K | 2/7/2024 |
| McKee Kelly T. Jr. | ▲ Buy | Open Market | 6,944 | $2K | 12/22/2023 |
| McKee Kelly T. Jr. | ▲ Buy | Open Market | 9,653 | $5K | 9/25/2023 |
| DODD DAVID A | ▲ Buy | Open Market | 35,087 | $20K | 8/25/2023 |
| Reynolds Mark | ▲ Buy | Open Market | 10,000 | $5K | 8/18/2023 |
| DODD DAVID A | ▲ Buy | Open Market | 32,000 | $20K | 4/24/2023 |
| Reynolds Mark | ▲ Buy | Open Market | 8,000 | $5K | 4/20/2023 |
| CHASE RANDAL D | ▲ Buy | Open Market | 10,000 | $11K | 9/21/2022 |
| Sharkey John W. | ▲ Buy | Open Market | 1,000 | $820 | 7/1/2022 |
| McKee Kelly T. Jr. | ▲ Buy | Open Market | 4,464 | $5K | 6/27/2022 |
| CHASE RANDAL D | ▲ Buy | Open Market | 10,000 | $12K | 6/21/2022 |
| McKee Kelly T. Jr. | ▲ Buy | Open Market | 9,722 | $7K | 5/5/2022 |
| McKee Kelly T. Jr. | ▲ Buy | Open Market | 4,999 | $4K | 5/4/2022 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
GeoVax Notes Sustained Clade Ib Mpox Transmission in US
GeoVax Labs reported that Clade Ib mpox transmission in the United States is likely to be sustained. This development is relevant as the company focuses on mpox-related solutions. The stock currently trades near its 52-week low, reflecting broader market conditions.
GeoVax Notes Sustained Clade Ib Mpox Transmission in US. GeoVax Labs reported that Clade Ib mpox transmission in the United States is likely to be sustained. This development is relevant as the company focuses on mpox-related solutions. The stock currently trades near its 52-week low, reflecting broader market conditions.